WO2007052296A3 - A process of preparing amorphous atorvastatin calcium - Google Patents
A process of preparing amorphous atorvastatin calcium Download PDFInfo
- Publication number
- WO2007052296A3 WO2007052296A3 PCT/IN2006/000306 IN2006000306W WO2007052296A3 WO 2007052296 A3 WO2007052296 A3 WO 2007052296A3 IN 2006000306 W IN2006000306 W IN 2006000306W WO 2007052296 A3 WO2007052296 A3 WO 2007052296A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- atorvastatin calcium
- amorphous atorvastatin
- preparing amorphous
- calcium
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A simple and economical process for the preparation of amorphous atorvastatin calcium in high purity and good yield from crystalline atorvastatin sodium without forming crystalline atorvastatin calcium is disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN996/MUM/2005 | 2005-08-23 | ||
IN996MU2005 | 2005-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007052296A2 WO2007052296A2 (en) | 2007-05-10 |
WO2007052296A3 true WO2007052296A3 (en) | 2007-11-15 |
Family
ID=38006307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000306 WO2007052296A2 (en) | 2005-08-23 | 2006-08-22 | A process of preparing amorphous atorvastatin calcium |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007052296A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI22255A (en) * | 2006-04-14 | 2007-10-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | New polymorphs of statine salts and their application in pharmaceutical formulations |
WO2008053495A1 (en) * | 2006-10-30 | 2008-05-08 | Lupin Limited | A novel crystalline form of atorvastatin sodium |
CN102935076A (en) * | 2012-11-29 | 2013-02-20 | 康普药业股份有限公司 | Capsule containing atorvastatin sodium and preparation method thereof |
CN113321607A (en) * | 2020-02-28 | 2021-08-31 | 北京福元医药股份有限公司沧州分公司 | Purification method of atorvastatin calcium intermediate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000071116A1 (en) * | 1999-05-25 | 2000-11-30 | Ranbaxy Laboratories Limited | Process for the production of amorphous atorvastatin calcium |
WO2002083638A1 (en) * | 2001-04-11 | 2002-10-24 | Cadila Healthcare Limited | Process for the production of atorvastatin calcium in amorphous form |
-
2006
- 2006-08-22 WO PCT/IN2006/000306 patent/WO2007052296A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000071116A1 (en) * | 1999-05-25 | 2000-11-30 | Ranbaxy Laboratories Limited | Process for the production of amorphous atorvastatin calcium |
WO2002083638A1 (en) * | 2001-04-11 | 2002-10-24 | Cadila Healthcare Limited | Process for the production of atorvastatin calcium in amorphous form |
Also Published As
Publication number | Publication date |
---|---|
WO2007052296A2 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006035277A3 (en) | Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium | |
WO2006024024A3 (en) | Solid and crystalline ibandronate sodium and processes for preparation thereof | |
WO2007047863A3 (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
PL1727795T3 (en) | Process for the production of atorvastatin calcium in amorphous form | |
IL187483A0 (en) | Process for preparing amorphous rosuvastatin calcium free of impurities | |
AU2005295234A8 (en) | High yield method of producing pure rebaudioside A | |
IL187578A0 (en) | Process for preparing pure amorphous rosuvastatin calcium | |
HUP0501067A2 (en) | Amorphous and crystalline forms of losartan potassium and process for their preparation | |
AU2003282383A1 (en) | A process for the preparation of high purity escitalopram | |
PL368984A1 (en) | Process for the preparation of crystalline imipenem | |
IL181868A0 (en) | Process for preparing forms of atorvastatin calcium substantially free of impurities | |
WO2007074475A3 (en) | Novel polymorphic forms of ibandronate | |
WO2007052296A3 (en) | A process of preparing amorphous atorvastatin calcium | |
HU0300761D0 (en) | Process for the production of amorphous atorvastatin calcium | |
ZA200608632B (en) | Process for forming amorphous atorvastatin calcium | |
AU2002367896A1 (en) | Process for the preparation of ceftiofur acid | |
HK1117141A1 (en) | Process for the preparation of a new crystalline atorvastatin hemicalcium salt polymorph form | |
AU2002356423A1 (en) | Process for the preparation of amorphous atorvastatin calcium | |
WO2007096903A3 (en) | New crystalline form of atorvastatin hemi-calcium | |
AU2001289303A1 (en) | Process for producing crystalline tagatose | |
EP1831171A4 (en) | Process for the preparation of novel amorphous montelukast sodium | |
WO2002094773A3 (en) | Process for the isolation of crystalline imipenem | |
AU2003269478A1 (en) | A novel process for amorphous rosuvastatin calcium | |
AU2003247327A1 (en) | Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form | |
AU2003219423A1 (en) | Process for the isolation of high purity crystalline citalopram base |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06842722 Country of ref document: EP Kind code of ref document: A2 |